Boston criteria v2.0 for cerebral amyloid angiopathy without hemorrhage: An MRI-neuropathological validation study.
Aaron SwitzerAntreas CharidimouStuart J McCarterPrashanthi VemuriAivi T NguyenScott A PrzybelskiTimothy G LesnickAlejandro A RabinsteinRobert D BrownDavid S KnopmanRonald C PetersenClifford R JackRobert Ross ReichardJonathan Graff-RadfordPublished in: medRxiv : the preprint server for health sciences (2023)
The Boston criteria v2.0 have low accuracy in patients who are asymptomatic or only have cognitive symptoms.. Additional biomarkers need to be explored to optimize CAA diagnosis in this population.